A federal case challenging the safety of mifepristone, used to treat miscarriages and to induce abortions early in pregnancy, is being transferred out of Texas to a federal court in Missouri.

The lawsuit demands the federal government restore its previous restrictions on mifepristone by requiring three in-person doctor visits, reducing the gestational period during which the medication can be taken from 10 weeks to seven and rolling back recent federal policy that allowed for the mailing of mifepristone and allowed for prescriptions to be made online or through pharmacies.

“This case has always been about ideology, not patient safety,” Emily Wales, president and CEO of Planned Parenthood Great Plains said in a statement Wednesday, “It’s no surprise it has now been transferred to a distri

See Full Page